Predictive markers for egfr inhibitors treatment

Details Predictive markers for egfr inhibitors treatment Predictive markers for egfr inhibitors treatment

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2695064

The present invention provides biomarkers that are predictive for the response to treatment with an EGFR inhibitor in cancer patients. The markers are the genes GBAS, APOH, SCYL3, PMS2CL, PRODH, SERFlA, URG4A and LRRC31.

La présente invention porte sur des biomarqueurs qui sont prédictifs de la réponse à un traitement par un inhibiteur de l'EGFR chez les patients cancéreux.

Affiliated with

Also associated with

Rating

Predictive markers for egfr inhibitors treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Predictive markers for egfr inhibitors treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predictive markers for egfr inhibitors treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1389427